1. Home
  2. VWAV vs CVRX Comparison

VWAV vs CVRX Comparison

Compare VWAV & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VWAV

VisionWave Holdings Inc.

HOLD

Current Price

$2.93

Market Cap

139.7M

Sector

Technology

ML Signal

HOLD

Logo CVRx Inc.

CVRX

CVRx Inc.

HOLD

Current Price

$4.76

Market Cap

139.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VWAV
CVRX
Founded
2024
2000
Country
United States
United States
Employees
12
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.7M
139.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
VWAV
CVRX
Price
$2.93
$4.76
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$10.50
AVG Volume (30 Days)
562.1K
279.2K
Earning Date
05-18-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
23.02
EPS
N/A
N/A
Revenue
N/A
$56,651,000.00
Revenue This Year
N/A
$17.17
Revenue Next Year
N/A
$17.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
10.45
52 Week Low
$3.13
$4.37
52 Week High
$15.80
$11.30

Technical Indicators

Market Signals
Indicator
VWAV
CVRX
Relative Strength Index (RSI) 30.82 39.68
Support Level N/A $4.37
Resistance Level $6.64 $5.96
Average True Range (ATR) 0.34 0.35
MACD -0.07 -0.04
Stochastic Oscillator 0.64 5.04

Price Performance

Historical Comparison
VWAV
CVRX

About VWAV VisionWave Holdings Inc.

VisionWave Holdings Inc is a technology company focused on the development and commercialization of artificial intelligence (AI) and autonomous solutions across air, ground and sea environments. Through its subsidiary, the Company designs and deploys technologies including radars, radio frequency (RF) sensing, unmanned aerial and ground systems, remote weapon stations and active protection systems for defense, military, homeland security and industrial applications. Its proprietary AI engine supports autonomous decision-making and product lines at various stages of development and commercialization. Revenue is generated through product sales, technology licensing, strategic alliances and joint ventures, with products including C-UAS, multi-purpose autonomous UAS and Vision-AI technology.

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Share on Social Networks: